Moolec Science (MLEC) Current Taxes (2023 - 2024)
Moolec Science (MLEC) reported Current Taxes of $4.8 million for Q2 2024, up 847.93% on a YoY basis from $509034.0 in Q3 2023, and up 847.93% sequentially from $509034.0 in Q2 2023.
Moolec Science (MLEC) Current Taxes (2023 - 2024) Analysis & Trends
Moolec Science (MLEC) has 2 years of Current Taxes data on file, last reported at $4.8 million in Q2 2024.
- For the quarter ending Q2 2024, Current Taxes rose 847.93% year-over-year to $4.8 million; the trailing twelve-month figure through Jun 2024 stood at $4.8 million (up 847.93% YoY), and the FY2024 full-year result was $4.8 million, up 847.93% from the prior year.
- Current Taxes grew to $4.8 million in Q2 2024, from $509034.0 in the prior quarter.
- In the past five years, Current Taxes ranged from a high of $4.8 million in Q2 2024 to a low of $509034.0 in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 63.52 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 49.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Moolec Science | 5.21 Bn | 5.21 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 4.83 Mn |
| Jun 30, 2023 | 509,034.00 |